Agoracom Blog Home

Posts Tagged ‘Marijuana’

« Older Entries
Newer Entries »

Empower Clinics $CBDT.ca Provides Corporate Updates Highlighting Triple Digit Patient Growth and Subsidiary Sun Valley Health Launches New Modalities and Patient Services $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 7:43 AM on Thursday, October 10th, 2019
  • Patient visits in corporate clinics increase by triple digits, with September 2019 patients seen increasing by 307% to 1,884 versus September 2018 with 614 patients seen
  • Launching seven new modalities and services for patients in the Sun Valley Health clinics

VANCOUVER, Oct. 10, 2019  – EMPOWER CLINICS INC. (CSE: CBDT) (OTC: EPWCF) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company, a multi-state operator of medical health & wellness clinics, a CBD product producer and operator of an extraction facility in Oregon, is pleased to announce it is launching seven new modalities and services for patients in the Sun Valley Health clinics commencing Monday October 14th, 2019.

The Company also has patient visits in corporate clinics increase by triple digits, with September 2019 patients seen increasing by 307% to 1,884 versus September 2018 with 614 patients seen.

“The tremendous year-over-year increase in patient visits is a testament to the operating strengths and patient management demonstrated by our clinic team members, each and every day,” said Steven McAuley, CEO of Empower. “Their passion for patient wellbeing and the use of numerous communication tools ensures world-class service is provided throughout the entire patient journey.”

As part of the Company’s continued expansion of our health & wellness clinic model, we have already set up retail CBD product sales in-clinic, and now we have launched expanded physician based services.

New Modalities and Services

  • Physician’s CBD Enhanced Massage, Acupuncture, or Cupping Sessions
  • CBD-Cannabis-Supplement Consumption & Coaching Consultation
  • Introduction to Alternative Health and Cannabinoid Therapies by a Physician
  • Comprehensive Naturopathic Patient Analysis & Consultation
  • Dietary Antigen Testing, Physician Consultation/Action Plan, & Concierge Blood Draw
  • Neurotransmitter (urine) Profile & Physician Consultation/Action Plan
  • Spectracell Micronutrient Test & Physician Consultation/Action Plan

“By offering our new suite of laboratory testing, alternative health consulting, and CBD therapies we are able to address the needs of our current patients and serve the community outside of cannabis that are seeking alternative health care,” states Dustin Klein, Director & VP Business Development. “Incorporating our new modalities, high quality vitamins, supplements, and CBD products into our network of clinics is a natural progression toward our goal of becoming the nation’s premier alternative healthcare provider.”

Additional UPDATES

  • New Modalities and Patient Services The Company continues to see patient visits in corporate clinics increase by triple digits, with September 2019 patients seen increasing by 307% to 1,884 over July 2018 614 patients seen.

  • Sun Valley Health Franchise Sun Valley Health www.sunvalleyhealth.com has been actively participating in various franchise and cannabis expos in St. Louis, Chicago and Houston to market the Sun Valley Health franchise program, attracting numerous qualified candidates for available territory locations. The Company has accepted many applications and has provided the Franchise Disclosure Document (FDD) to qualified applicants in anticipation of completing the first initial territory sales.

ABOUT EMPOWER

Empower is a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the terms of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

Tags: , , , , , ,
Posted in Empower Clinics Inc., Featured | Comments Off on Empower Clinics $CBDT.ca Provides Corporate Updates Highlighting Triple Digit Patient Growth and Subsidiary Sun Valley Health Launches New Modalities and Patient Services $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

PODCAST: Why #cannabis 3.0 is the real opportunity for Canada with Bruce Linton – SPONSOR: #NORTHBUD $NBUD.ca $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 12:55 PM on Wednesday, October 9th, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE
—————————–

PODCAST: Why ‘cannabis 3.0’ is the real opportunity for Canada with Bruce Linton

By: Emily Jackson

Welcome to Down to Business, a weekly podcast from the Financial Post.

It’s been one year since Canada legalized the recreational cannabis industry after a century of prohibition. But it’s just the beginning of the journey from the black market to “cannabis 3.0.”

In the lead-up to the election, Down to Business has focused on business issues with a political twist. This week, host Emily Jackson discusses the cannabis industry’s one-year legalization anniversary with Bruce Linton, the former chief executive of Canopy Growth, Canada’s largest cannabis company.

Linton discusses lessons from the first round of legalization for recreational use, what to expect from the impending introduction of cannabis infused beverages and edibles, and why Canada needs to focus on “cannabis 3.0” if it wants to be a global leader.

You can listen below — or on Apple Podcasts, Spotify, Stitcher and Google Play, where you can also subscribe to get new episodes every Wednesday morning.

Source: https://business.financialpost.com/cannabis/cannabis-business/down-to-business-podcast-why-cannabis-3-0-is-the-real-opportunity-for-canada

Tags: , , , , , , , , ,
Posted in North Bud Farms Inc | Comments Off on PODCAST: Why #cannabis 3.0 is the real opportunity for Canada with Bruce Linton – SPONSOR: #NORTHBUD $NBUD.ca $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Bougainville Ventures Inc. Appoints Mr. Andy Dhaliwal, President of Thrive Nutrition to Vice President of Sales and Distribution $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 7:54 AM on Tuesday, October 8th, 2019
  • Company has appointed Mr. Andy Dhaliwal, President of Thrive Wellness to Vice President of Sales and Distribution for Bougainville Ventures Inc. 

VANCOUVER, British Columbia, Oct. 08, 2019 — BOUGAINVILLE VENTURES INC. (CSE: BOG) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Bougainville” or the “Company”) is pleased to announce that further to the signing of the definitive agreement to complete the acquisition of Thrive Nutrition Products Ltd. (“Thrive Wellness”) announced in the Company news release dated September 24, 2019, the Company has appointed Mr. Andy Dhaliwal, President of Thrive Wellness to Vice President of Sales and Distribution for Bougainville Ventures Inc.  Thrive Wellness is a preeminent distributor of hemp & cannabinoid-focused natural health products under the “THRIVE WELLNESS” brand.

About Thrive Nutrition Products Ltd.
Thrive Wellness is a distributor of premium hemp and natural health products with operations currently in Canada and the USA. Thrive specializes in the development, marketing and distribution of cannabinoid products refined into their own natural health product brand. The company was founded in Vancouver, British Columbia and is the first of its kind with national retail distribution in Canada. Thrive has achieved $2,500,000 CDN in sales through retail distribution, its’ e-commerce website and their relationship with Nutrition House, Canada’s leading Natural Health Product franchise. Founded in 1979 the company began franchising in 1993 and now operates over 45 retail stores, located in high profile shopping centers across Canada, and in the USA. www.nutritionhouse.com

CEO, Andy Dhaliwal Comments:

“I am very excited to be a joining a team that is extremely well positioned for significant growth in the emerging cannabis & hemp markets. I look forward to helping Bougainville continue building shareholder value and to increase our international exposure through this partnership. I am particularly keen on the CBD opportunity in the U.S., where Bougainville already has resources available.”

Mr. Dhaliwal is a pioneering expert in the marketing of cannabis, hemp, and natural health products, and brings over 12 years of experience in the industry. In addition to serving as the CEO of Thrive Wellness, he was an advisor for the Province of British Columbia’s Cannabis Operations, where he advised on corporate development and sales optimization. 

To learn more about what this news means to the shareholders visit https://marketnewsfirst.com/bog-news, as well as on the company’s site.

About the CBD Market

Bank of America projects a spend of $1.3 Billion on CBD in Canada by 2022, while $1.9 Billion is being spent in the USA currently, and another $4.4 Billion in Europe this year. Demand for CBD and Hemp is increasing year over year, with Merrill Lynch predicting an $11.5 Billion American market by 2032.

About Bougainville Ventures, Inc.

Bougainville Ventures Inc. is dedicated to rapid growth in production, processing, retail and branding of cannabis and cannabis related products. Currently the company provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. We offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Also, the Company is focused on building a strong presence in the hemp industry with the objective of extracting cannabinoids in both Canada and the United States. Along with our flagship Hemp project in Oregon State and the Greenhouse campus in Washington State, the Company has proprietary formulas for cannabis edibles, topical, and tinctures.

On behalf of the Board of Directors
BOUGAINVILLE VENTURES INC.

Andy Jagpal, President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305 [email protected]. Or toll free at 1-877-517-7816

http://bougainvilleinc.com/https://twitter.com/bougainvilleincwww.thriveCBD.org

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

No regulatory authority has approved or disapproved the information contained in this news release.

Tags: , , , , , ,
Posted in Bougainville Ventures | Comments Off on Bougainville Ventures Inc. Appoints Mr. Andy Dhaliwal, President of Thrive Nutrition to Vice President of Sales and Distribution $CROP.ca $VP.ca NF.ca $MCOA

Another First for the #Pot Industry: A Licensed Cannabis Restaurant SPONSOR: NORTHBUD $NBUD.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 10:01 AM on Monday, October 7th, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE
—————————–

Another First for the Pot Industry: A Licensed Cannabis Restaurant

  • Cannabis edibles are a growing segment of the market and are expected to reach $4.1 billion in 2022, combining Canadian and U.S. sales.
  • In 2017, that figure was just $1 billion among the two countries. The segment is going to be key to the industry’s long-term growth.

By: David Jagielski

Cannabis edibles are a growing segment of the market and are expected to reach $4.1 billion in 2022, combining Canadian and U.S. sales. In 2017, that figure was just $1 billion among the two countries. The segment is going to be key to the industry’s long-term growth.

Restaurants haven’t been able to take advantage of that growth since the U.S. Food and Drug Administration has still not permitted cannabidiol (CBD) to be infused into food. While the FDA has held hearings on CBD, there’s no indication that changes are coming anytime soon.

One restaurant, however, has been able to get around that problem. Lowell Farms opened its doors earlier this month in West Hollywood, Calf., and it’s the first restaurant with a lounge licensed for cannabis use. Customers will be able to eat food and consume pot at the same establishment. That doesn’t mean the restaurant will be able to make and serve cannabis food. Instead, cannabis edibles will be permitted only if they are “produced by an outside source.” 

One of the other restrictions the restaurant will face is not being able to sell alcohol to diners. It’s a small price to pay to let them consume cannabis, since pot lounges remain a rarity in the industry. Las Vegas is among the cities looking at permitting such lounges, but that could be years away because there’s still a lot of opposition to it. 

Will a bar someday be a place to enjoy pot with friends? Image source: Getty Images.

Why lounges could be big for the industry

While marijuana has been legalized in many parts of the U.S., that doesn’t mean it’s possible to consume it at bars or sporting events, unlike alcohol where there are many places that users can drink in a social setting. Allowing that could unlock another avenue of growth for the industry.

Cannabis beverages are on the rise and expected to grow globally at a rate of more than 15% per year from now until 2025, reaching $4.5 billion in market size by then. So there’s going to be a growing need for places to enjoy such drinks with friends without always having to do so at home. And that doesn’t even factor in the growth of edibles that could be consumed at lounges, such as candy, cookies, and chocolate.

In Canada, there’s potential for Canopy Growth to test its products in one lounge that was made legal earlier this year. In many ways, the emerging Canadian cannabis edibles market, which is going to be legalized later this month and where the first products will be available in December , could prove to be a good indicator of how successful some of these concepts will be in the U.S. And for Canopy Growth, it could be an important way to get closer to breakeven.

For now, Canopy Growth can be a good opportunity for investors to take advantage of the new edibles market in Canada. Not only is the company well-positioned for success in the beverages segment, but in a recent interview with BNN Bloomberg, CEO Mark Zekulin said the company was working on more than 50 different products for the edibles market. That could lead to significant growth for Canopy Growth and get investors excited about the stock once again.

Here’s The Marijuana Stock You’ve Been Waiting For

A little-known Canadian company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

And make no mistake – it is coming.

Cannabis legalization is sweeping over North America – 10 states plus Washington, D.C., have all legalized recreational marijuana over the last few years, and full legalization came to Canada in October 2018.

And one under-the-radar Canadian company is poised to explode from this coming marijuana revolution.

Because a game-changing deal just went down between the Ontario government and this powerhouse company…and you need to hear this story today if you have even considered investing in pot stocks.

Source: https://www.fool.com/investing/2019/10/06/another-first-for-the-cannabis-industry-a-licensed.aspx

Tags: , , , , , , , ,
Posted in All Recent Posts, North Bud Farms Inc | Comments Off on Another First for the #Pot Industry: A Licensed Cannabis Restaurant SPONSOR: NORTHBUD $NBUD.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Vertical Exploration $VERT.ca Enters into an LOI with Venturevest Realty Partners for Note Facility to Support Significant St-Onge Wollastonite Development $TORR.ca $FA.ca $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM at 12:36 PM on Thursday, October 3rd, 2019
http://www.smallcapepicenter.com/Vert%20Square.png

VANCOUVER, BC / ACCESSWIRE / October 3, 2019 /VERTICAL EXPLORATION INC. (TSXV:VERT) (“Vertical” or “the Company”) and Venturevest Realty Partners LLC (“Venturevest”) are pleased to announce that the two companies have signed a non- binding Letter of Intent (LOI) to enter into discussions regarding the provision by Venturevest of a secured Note Facility up to a maximum amount of $20 million CAD to support the multi-phased development of the St-Onge Wollastonite Deposit.

The Note Facility would be a staged credit facility that would provide the required financing to allow Vertical to move forward with four distinct phases of St-Onge development, from the initial quarry style permitting and production phase through to the mining and final processing plant stage. Vertical views this potential Note Facility financing as a significant development that would enable the Company to rapidly develop and expand its St-Onge Wollastonite Deposit.

Further details regarding the Note Facility Agreement will be provided as soon as all terms have been negotiated between Vertical and Venturevest. The Agreement is subject to a due diligence period that is anticipated to be completed within the next 60 days. This transaction is subject to the approval of the TSX Venture Exchange.

ABOUT VENTUREVEST REALTY PARTNERS LLC.

Venturevest Realty Partners LLC (“Venturevest”) is a New York corporation.

ABOUT VERTICAL EXPLORATION

Vertical Exploration’s mission is to identify, acquire, and advance high potential mining prospects located in North America for the benefit of its stakeholders. The Company’s flagship St-Onge Wollastonite property is located in the Lac-Saint-Jean area in the Province of Quebec.

ON BEHALF OF THE BOARD

Peter P. Swistak, President/CEO

FOR FURTHER INFORMATION PLEASE CONTACT:

Telephone: 1-604-683-3995
Toll Free: 1-888-945-4770
https://vertxinc.com/

Tags: , , , , , , , , , , ,
Posted in All Recent Posts, Vertical Exploration Inc | Comments Off on Vertical Exploration $VERT.ca Enters into an LOI with Venturevest Realty Partners for Note Facility to Support Significant St-Onge Wollastonite Development $TORR.ca $FA.ca $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

NORTHBUD $NBUD.ca – As Canada gears up for pot 2.0, more shortages are on the menu $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 12:07 PM on Thursday, October 3rd, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE
—————————–
  • Canada’s legalization of pot edibles later this year is facing an even more shambolic start than the dried flower market, which is still struggling to meet demand, according to industry players.

Kristine Owram, Bloomberg News

Canada’s legalization of pot edibles later this year is facing an even more shambolic start than the dried flower market, which is still struggling to meet demand, according to industry players.

“At least that time we knew what the permissible product types were going to be and were already making them in the medical context,” said cannabis lawyer Trina Fraser, a partner at Brazeau Seller Law in Ottawa.

Canada will add edibles, extracts and topicals to the list of legal cannabis products no later than Oct. 17. Many analysts agree these products will generate better demand and margins than dried flower. But the federal government has not yet issued regulations for the new formats, making it difficult for producers to prepare lest they unknowingly violate some rule.

A spokeswoman for Health Canada declined to comment on when the regulations will be released.

In addition, a huge licensing backlog has built up at Health Canada, the government agency that oversees cannabis regulations. About 614 applications were waiting in the queue as of March 31.

“A full rollout amongst a nice wide array of producers and a wide array of these new product types is going to take time, literally years, because we have such a licensing backlog,” Fraser said.

Company Stockpiling

Canada’s market for edibles and other alternative pot produces will eventually be worth C$2.7 billion ($2 billion) annually, but consumers should expect “missteps, delays and frustration” in the early days, Deloitte said in a report published Monday. Jennifer Lee, Deloitte Canada’s cannabis national leader, estimated it will be a minimum of 24 months before the industry normalizes.

In the meantime, many pot companies are stockpiling, choosing to forgo revenue today to ensure they have enough supply for the new high-value products. This is exacerbating the shortage of dried flower, but executives say it’s worth it.

“We’ve made a very conscious effort to delay revenue,” said Chuck Rifici, chief executive officer of Auxly Cannabis Group Inc. Selling into the market today doesn’t build brand recognition because shelves are empty and consumers are buying whatever’s available, he added. “I would much rather save that product, get a multiple of margin on that brand and make sure that I have enough inventory.”

Lab Delays

This is proving to be a boon for extraction companies like Valens GroWorks Corp. Valens has contracts with many of the biggest pot companies, including Canopy Growth Corp., Hexo Corp. and Tilray Inc., to extract cannabis oil from their plants, which is then used for products like edibles and vape cartridges. It’s also investing heavily in its testing labs in the belief that Health Canada will have stringent regulations to ensure pesticides and other contaminants don’t make it into the new consumer products.

“Even in labs today there’s delays where people are waiting three weeks to a month to get lab results back and I think that will only get worse,” said Everett Knight, Valens’ executive vice president of strategy and investments.

Companies are also making big bets on what products will be in demand, with Canopy and Hexo leaning toward cannabis beverages and others toward vaping.

Be Prepared

“Why do I want an edible or a drink when I can have a vape?” Irwin Simon, interim CEO of Aphria Inc., said in an interview on the sidelines of a cannabis conference last month. “I see the margins and the opportunities there.”

Rifici at Auxly also believes vape pens will be “the most important category by far.” But there are many unanswered questions. For example, will the government require companies to engrave its mandatory THC warning symbol into the pen itself, or will a sticker suffice?

This is why Valens is offering its customers 196 different options for its white-label vape pens. “You’ve got to make sure you cover your bases and prepare for all the possibilities,” Knight said.

Despite the uncertainty, it’s better to be prepared even if plans and production lines have to be tweaked once the regulations come out, said Bruce Linton, CEO of Canopy, which is building a 197,000 square foot bottling plant for cannabis beverages in Smiths Falls, Ontario.

“We’re in a situation where it’s better to spend money to be ready than to save money and be late,” he said.

 Cannabis Canada is BNN Bloomberg’s in-depth series exploring the stunning formation of the entirely new – and controversial – Canadian recreational marijuana industry. Read more from the special series here and subscribe to our Cannabis Canada newsletter to have the latest marijuana news delivered directly to your inbox every day.

Source: https://www.bnnbloomberg.ca/as-canada-gears-up-for-pot-2-0-more-shortages-are-on-the-menu-1.1268844

Tags: , , , , , , , , ,
Posted in All Recent Posts, North Bud Farms Inc | Comments Off on NORTHBUD $NBUD.ca – As Canada gears up for pot 2.0, more shortages are on the menu $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Benefits #CBD oil promotes for your health – SPONSOR: Empower Clinics $CBDT.ca $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 12:03 PM on Wednesday, October 2nd, 2019

Why Empower Clinics

  • A leading owner/operator of physician staffed health and pain management clinics
  • Patient database of over 165,000 patients 
  • Platform generating $4MM USD in revenue annually (2019)
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Launching CBD extraction facility
  • First extraction system capacity = 6,000 Kg per year.
  • CBD based products are poised to be a $20B global industry by 2022
  • Medical cannabis is poised to be a $100B global industry by 2025

Benefits CBD oil promotes for your health

CBD oil is a much talked about product, it is a topic of hot conversation, it is in the news and everyone has an opinion! Some opinions are based on fact, others on assumption and there are a group of people who just do not know what to think at all. This article will attempt to provide you with some information as to the possible health benefits which can be derived from taking CBD oil. CBD oil has much recent research attached and there is also increasing testimony from those who regularly take the product for a number of very different conditions from which they are suffering.

The first point to mention is that CBD or to give it its chemical name, Cannabidiol, should not be confused with its sister chemical THC or Tetrahydrocannabinol. Both chemicals are derived from the cannabis plant which in itself has over 100 chemicals and although the two chemicals are similar in a sense, they differ in the way in which their atoms are put together. Here, in the UK, CBD is legal to purchase whether it be as an oil or as part of another preparation.  It is the THC which is not legal and any product containing CBD can only contain trace elements of THC at the most, in fact products can contain no more than 0.2% THC. Each country has their own rules and so if you are planning to use CBD anywhere else other than in the UK, you should check the legal status first.

CBD is extracted from the cannabis plant using different processes and each manufacturer will use their own particular method of extraction. When the CBD has been extracted, it will then be mixed with a carrier oil and it is then known as CBD oil.

Many people have conditions which cause them to be in serious pain or have quite debilitating symptoms. Sometimes conditions can be treated and sometimes they cannot be treated and instead they are managed by medication, which is not the best solution for a long term problem. CBD has shown promise in giving relief and even turning around certain conditions. Evidence for its effectiveness has come in anecdotal form from those who have used the product and it comes also with scientific back up for many conditions and as more and more research emerges with results, CBD is becoming a go to product of choice for many. So what conditions is CBD oil known to help?

  • Chronic pain can be significantly lessened
  • Anxiety can be relieved
  • Depression
  • Stress
  • Both rheumatoid arthritis and osteoarthritis
  • Seizures including epilepsy
  • Inflammation
  • Nausea
  • Chronic headaches and migraines
  • MS
  • Parkinsons
  • Alzheimers
  • Obesity
  • Cancers

And the list goes on, in fact conditions throughout the body can be addressed using CBD oil.

It is not something that we are used to as when we are given ‘a pill for an ill’, we would not expect to receive the same pill for a headache and an infection for example, yet CBD would appear to treat and relieve many non similar conditions, the following provides an explanation as to why that is the case.

Our body is a complex series of structures which we have grouped into systems, we have the Nervous system, the Cardiovascular system, the Immune system and so on but one system which was only discovered around 30 years ago is the Endocannabinoid system. This system is the system which is responsible for bringing about an equilibrium or balance to the body, sometimes referred to as homeostasis. It does this via cannabinoid receptors. These receptors look for cannabinoids to attach to them and when they are satisfied that they have their requirement, the balance is restored and as long as the supply and uptake is maintained, so is the balance. When the system becomes unbalanced, the receptors are not fulfilled and when that balance is no longer there, illness and pain are felt. The body naturally produces its own endocannabinoids, sometimes it will not produce enough and sometimes the endocannabinoid being produced fail to reach the receptor points. CBD is a cannabinoid and it is thought that it works with the bodies own system to satisfy the receptors. This is why CBD can be used for all manner of illnesses and difficulties within the body. It can even be used in lower doses by healthy people to keep their system in check and many use it for this purpose.

Each person will have a dose that suits them best and it is up to each user to find that dose. It is always tempting to read about all of the good that a product has to offer and go about taking a high dose to try to access some of that good but this is the wrong way to go. Start with a small amount and gradually increase the amount until you feel a benefit. At that point, that should be the dose that suits you. Start with the weakest preparation and if you need to move to a stronger preparation, do that next. Do not assume that you will be able to copy the dose that someone else is taking, that is just not true, you have to work slowly to find your own.

Source: https://augustafreepress.com/benefits-cbd-oil-promotes-for-your-health/

Tags: , , , , , , , ,
Posted in Empower Clinics Inc. | Comments Off on Benefits #CBD oil promotes for your health – SPONSOR: Empower Clinics $CBDT.ca $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

The Top Most Compelling Reasons to Invest in the #CBD Market – SPONSOR: #Bougainville Ventures $BOG.ca $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 10:52 AM on Wednesday, October 2nd, 2019

SPONSOR:  Bougainville Ventures Inc (CSE: BOG) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

The Top Most Compelling Reasons to Invest in the CBD Market

  • According to Grand View Research, the global CBD market could see a compound annual growth rate of 32.6% to $9.7billion by 2025.
  • The firm also projects that the global CBD skincare segment of the market could grow at a CAGR of 33% to $1.7 billion by 2025.

The CBD boom is here, and it’s thriving especially as major retailers just on board.  Already, Neiman Marcus, Sephora, Vitamin Shoppe, Kroger, Barney’s DSW, CVS, American Eagle, and Walgreen’s are selling CBD products. Even Shopify is now offering features for U.S. retailers of hemp and CBD, expanding its North American reach. On top of that, support for cannabis legalization is exploding. For example, a Gallup survey found that 66% of Americans are in favor of legalization. That’s up from just 60% in 2016. In addition, according to Grand View Research, the global CBD market could see a compound annual growth rate of 32.6% to $9.7billion by 2025. The firm also projects that the global CBD skincare segment of the market could grow at a CAGR of 33% to $1.7 billion by 2025.

Read More: https://www.baystreet.ca/stockstowatch/6528/The-Top-Most-Compelling-Reasons-to-Invest-in-the-CBD-Market

Tags: , , , , , ,
Posted in Bougainville Ventures | Comments Off on The Top Most Compelling Reasons to Invest in the #CBD Market – SPONSOR: #Bougainville Ventures $BOG.ca $CROP.ca $VP.ca NF.ca $MCOA

#CBD Use Continues to Grow as Regulators Change Tact , bodes well for #Bougainville Ventures $BOG.ca $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 11:17 AM on Tuesday, October 1st, 2019

SPONSOR:  Bougainville Ventures Inc (CSE: BOG) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

CBD Use Continues to Grow as Regulators Change Tact , bodes well for Bougainville Ventures

  • According to data compiled by Grand View Research, the global cannabidiol market is expected to reach USD 9.69 Billion by 2025 while registering a CAGR of 32.6% during the forecast period.

NEW YORK, Oct. 1, 2019 — Hemp has been used for centuries for its multi-facet applications. Previously, hemp was primarily used for industrial applications such as manufacturing textiles, fabrics, and linen. The industrial segment was the largest driver for the overall hemp market, however, following legislative efforts, the hemp-derived CBD market has emerged as the primary driver. Hemp was also commonly used as a medicinal treatment for convulsions, rheumatism, dysentery, and insomnia. However, health officials around the world had deemed hemp unsafe for consumers because it was derived from the cannabis plant.

As a result, the entire cannabis plant was listed as a Schedule 1 substance solely because of its marijuana component. The marijuana plant is packed with tetrahydrocannabinol (THC), while the hemp plant is typically cannabidiol (CBD) dominant. Although the two plants fall under the cannabis family, they are widely different in their genetic makeup and effects.

THC is the compound that is commonly known to cause psychoactive effects on the consumer, while CBD is generally known to have relaxing and soothing effects. However, despite the genetic differences, both THC and CBD are known to alleviate certain medical conditions. Researchers have even highlighted that both THC and CBD can effectively treat symptoms associated with cancer, chronic pain, epilepsy, Alzheimer’s, and Parkinson’s. However, because THC causes mind-altering effects, health officials are more inclined to accept CBD as a medicinal treatment than THC. As a result, countries such as Canada, Germany, South Korea, the U.K., and the U.S. have legalized CBD for medical purposes. According to data compiled by Grand View Research, the global cannabidiol market is expected to reach USD 9.69 Billion by 2025 while registering a CAGR of 32.6% during the forecast period.

Read More: https://www.prnewswire.co.uk/news-releases/cbd-use-continues-to-grow-as-regulators-change-tact-829476982.html

Tags: , , , , , ,
Posted in All Recent Posts, Bougainville Ventures | Comments Off on #CBD Use Continues to Grow as Regulators Change Tact , bodes well for #Bougainville Ventures $BOG.ca $CROP.ca $VP.ca NF.ca $MCOA

Bougainville Ventures $BOG.ca Oregon Hemp Farm Begins Harvesting $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 6:50 AM on Tuesday, October 1st, 2019
  • hemp farm in Oregon has a crew of 20 people harvesting 28,000 plants and will be completed over the next couple of weeks
  • Worm Casting team has arranged for drying of the bio-mass with a local drying facility close by while our 15,000 Sq ft., drying facility is being built.
  • Once processed, it will be sold along with the 28 kg of distillate CBD oil that was processed by Dab Extraction Associates a mobile extraction company earlier this year.

Vancouver, British Columbia–(October 1, 2019) – BOUGAINVILLE VENTURES INC. (CSE: BOG) (OTC Pink: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Bougainville” or the “Company”) is pleased to announce that harvesting on the Oregon Hemp farms has begun. The hemp farm in Oregon has a crew of 20 people harvesting 28,000 plants and will be completed over the next couple of weeks.

The Worm Casting team has arranged for drying of the bio-mass with a local drying facility close by while our 15,000 Sq ft., drying facility is being built. Once processed, it will be sold along with the 28 kg of distillate CBD oil that was processed by Dab Extraction Associates a mobile extraction company earlier this year.



Harvest Begins

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6334/48347_5298ce62f42f2863_001full.jpg

Andy Jagpal, President Comments:

“The hemp Industry in Oregon is booming and so is the demand for CBD. According to an Oregon based Hemp publication there were little over 580 growers, and 11,500 acres growing Hemp registered in 2018. This year, there are 1,900 growers, and nearly 63,000 acres registered growing hemp. The Hemp market is bigger than the medical marijuana and recreational marijuana put together, and as the Baby Boomers are just now discovering the benefits of CBD the demand for Hemp has an aggressive growth curve that is just beginning.”

To learn more about what this news means to the shareholders visit https://marketnewsfirst.com/bog-news

About the Hemp Market

In 2018, the legal cannabis market was valued at $11.9 billion in the United States and is expected to be worth $66.3 billion by the end of 2025, which is a compounded annual growth rate of nearly 24 percent, according to Market Research.

About Bougainville Ventures, Inc.

Bougainville Ventures Inc. is dedicated to rapid growth in production, processing, retail and branding of cannabis and cannabis related products. Currently the company provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. We offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Also, the Company is focused on building a strong presence in the hemp industry with the objective of extracting cannabinoids in both Canada and the United States. Along with our flagship Hemp project in Oregon State and the Greenhouse campus in Washington state, the Company has proprietary formulas for cannabis edibles, topical, and tinctures.

On behalf of the Board of Directors
BOUGAINVILLE VENTURES INC.

Andy Jagpal, President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305 [email protected]. Or toll free at 1-877-517-7816

http://bougainvilleinc.com/
https://twitter.com/bougainvilleinc

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

No regulatory authority has approved or disapproved the information contained in this news release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/48347

Tags: , , , , , ,
Posted in Bougainville Ventures | Comments Off on Bougainville Ventures $BOG.ca Oregon Hemp Farm Begins Harvesting $CROP.ca $VP.ca NF.ca $MCOA

« Older Entries
Newer Entries »